Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Toxic nephropathies.

J H Sondheimer1, S D Migdal

  • 1Wayne State University School of Medicine, Detroit, Michigan.

Critical Care Clinics
|October 1, 1987
PubMed
Summary
This summary is machine-generated.

Drug and toxin-induced kidney damage is a critical concern, especially in critically ill patients. This review details specific toxins, their mechanisms, clinical signs, and management strategies for kidney injury.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sterile peritonitis because of splenic infarction in a patient on peritoneal dialysis: an unusual presentation.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis·2013
Same author

An analysis of the adequacy of preparation for end-stage renal disease care in Michigan. Michigan Renal Plan Task Force.

ASAIO journal (American Society for Artificial Internal Organs : 1992)·1995
Same author

The glomerulopathy of homozygous sickle hemoglobin (SS) disease: morphology and pathogenesis.

Journal of the American Society of Nephrology : JASN·1991
Same author

Mannitol-induced acute renal failure.

Medicine·1990
Same author

Doppler-detected tricuspid, mitral or aortic regurgitation in end-stage renal disease.

The American journal of cardiology·1989
Same author

Elevated plasma copper in chronic renal failure.

The American journal of clinical nutrition·1988
Same journal

Critical Care and Contagion: Evolving Frontiers of Infectious Diseases in the Modern Intensive Care Unit.

Critical care clinics·2026
Same journal

Advances and Challenges in Sepsis Care in Low-Resource Settings.

Critical care clinics·2026
Same journal

The Respiratory Triple Pandemic in the Intensive Care Unit: Epidemiology, Clinical Features and Management of COVID-19, Influenza and Respiratory Syncytial Virus.

Critical care clinics·2026
Same journal

Antibiotic Stewardship for the Intensivist.

Critical care clinics·2026
Same journal

Infection Prevention and Control in the Intensive Care Unit.

Critical care clinics·2026
Same journal

Antibiotic Considerations in the Critically Ill: Empiric Choices and Dosing.

Critical care clinics·2026
See all related articles

Area of Science:

  • Nephrology
  • Toxicology
  • Critical Care Medicine

Background:

  • Kidney damage from drugs and toxins is a significant clinical issue.
  • It disproportionately affects critically ill patients, complicating treatment and prognosis.
  • Understanding these injuries is vital for effective patient care.

Purpose of the Study:

  • To introduce the general topic of drug- and toxin-induced kidney damage.
  • To examine specific nephrotoxic agents in detail.
  • To elucidate mechanisms, clinical presentations, and management of toxic nephropathies.

Main Methods:

  • Review of existing literature on nephrotoxicity.
  • Detailed examination of specific drug and toxin classes.
  • Analysis of mechanisms of kidney injury, clinical manifestations, and therapeutic approaches.

Related Experiment Videos

Main Results:

  • Identification of key drugs and toxins causing kidney damage.
  • Elucidation of diverse mechanisms underlying toxic nephropathies.
  • Description of characteristic clinical features and diagnostic challenges.
  • Outline of evidence-based management strategies for acute kidney injury.

Conclusions:

  • Drug- and toxin-induced kidney damage requires careful consideration in critically ill patients.
  • Knowledge of specific agents, mechanisms, and clinical features aids diagnosis and management.
  • Prompt recognition and appropriate intervention can improve outcomes in toxic nephropathies.